Global Amifostine Market Outlook 2023

Report ID: 1131001 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
1 Amifostine Market Overview
    1.1 Product Overview and Scope of Amifostine
    1.2 Amifostine Segment by Type
        1.2.1 Global Amifostine Sales Growth Rate Comparison by Type (2021-2027)
        1.2.2 400mg/Dose
        1.2.3 500mg/Dose
    1.3 Amifostine Segment by Application
        1.3.1 Global Amifostine Sales Comparison by Application: (2021-2027)
        1.3.2 Head and Neck Cancer Adjuvant Therapy
        1.3.3 Others
    1.4 Global Amifostine Market Size Estimates and Forecasts
        1.4.1 Global Amifostine Revenue 2016-2027
        1.4.2 Global Amifostine Sales 2016-2027
        1.4.3 Amifostine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Amifostine Market Competition by Manufacturers
    2.1 Global Amifostine Sales Market Share by Manufacturers (2016-2021)
    2.2 Global Amifostine Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global Amifostine Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers Amifostine Manufacturing Sites, Area Served, Product Type
    2.5 Amifostine Market Competitive Situation and Trends
        2.5.1 Amifostine Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Amifostine Players Market Share by Revenue
        2.5.3 Global Amifostine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Amifostine Retrospective Market Scenario by Region
    3.1 Global Amifostine Retrospective Market Scenario in Sales by Region: 2016-2021
    3.2 Global Amifostine Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.3 North America Amifostine Market Facts & Figures by Country
        3.3.1 North America Amifostine Sales by Country
        3.3.2 North America Amifostine Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Amifostine Market Facts & Figures by Country
        3.4.1 Europe Amifostine Sales by Country
        3.4.2 Europe Amifostine Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Amifostine Market Facts & Figures by Region
        3.5.1 Asia Pacific Amifostine Sales by Region
        3.5.2 Asia Pacific Amifostine Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Amifostine Market Facts & Figures by Country
        3.6.1 Latin America Amifostine Sales by Country
        3.6.2 Latin America Amifostine Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Amifostine Market Facts & Figures by Country
        3.7.1 Middle East and Africa Amifostine Sales by Country
        3.7.2 Middle East and Africa Amifostine Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Amifostine Historic Market Analysis by Type
    4.1 Global Amifostine Sales Market Share by Type (2016-2021)
    4.2 Global Amifostine Revenue Market Share by Type (2016-2021)
    4.3 Global Amifostine Price by Type (2016-2021)

5 Global Amifostine Historic Market Analysis by Application
    5.1 Global Amifostine Sales Market Share by Application (2016-2021)
    5.2 Global Amifostine Revenue Market Share by Application (2016-2021)
    5.3 Global Amifostine Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 Clinigen
        6.1.1 Clinigen Corporation Information
        6.1.2 Clinigen Description and Business Overview
        6.1.3 Clinigen Amifostine Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 Clinigen Amifostine Product Portfolio
        6.1.5 Clinigen Recent Developments/Updates
    6.2 Sun Pharmaceutical
        6.2.1 Sun Pharmaceutical Corporation Information
        6.2.2 Sun Pharmaceutical Description and Business Overview
        6.2.3 Sun Pharmaceutical Amifostine Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 Sun Pharmaceutical Amifostine Product Portfolio
        6.2.5 Sun Pharmaceutical Recent Developments/Updates
    6.3 Taj Pharmaceuticals
        6.3.1 Taj Pharmaceuticals Corporation Information
        6.3.2 Taj Pharmaceuticals Description and Business Overview
        6.3.3 Taj Pharmaceuticals Amifostine Sales, Revenue and Gross Margin (2016-2021)
        6.3.4 Taj Pharmaceuticals Amifostine Product Portfolio
        6.3.5 Taj Pharmaceuticals Recent Developments/Updates
    6.4 Merro Pharmaceutical
        6.4.1 Merro Pharmaceutical Corporation Information
        6.4.2 Merro Pharmaceutical Description and Business Overview
        6.4.3 Merro Pharmaceutical Amifostine Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Merro Pharmaceutical Amifostine Product Portfolio
        6.4.5 Merro Pharmaceutical Recent Developments/Updates
    6.5 Luye Pharma
        6.5.1 Luye Pharma Corporation Information
        6.5.2 Luye Pharma Description and Business Overview
        6.5.3 Luye Pharma Amifostine Sales, Revenue and Gross Margin (2016-2021)
        6.5.4 Luye Pharma Amifostine Product Portfolio
        6.5.5 Luye Pharma Recent Developments/Updates
    6.6 Mingren Pharma
        6.6.1 Mingren Pharma Corporation Information
        6.6.2 Mingren Pharma Description and Business Overview
        6.6.3 Mingren Pharma Amifostine Sales, Revenue and Gross Margin (2016-2021)
        6.6.4 Mingren Pharma Amifostine Product Portfolio
        6.6.5 Mingren Pharma Recent Developments/Updates

7 Amifostine Manufacturing Cost Analysis
    7.1 Amifostine Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Amifostine
    7.4 Amifostine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Amifostine Distributors List
    8.3 Amifostine Customers

9 Amifostine Market Dynamics
    9.1 Amifostine Industry Trends
    9.2 Amifostine Growth Drivers
    9.3 Amifostine Market Challenges
    9.4 Amifostine Market Restraints

10 Global Market Forecast
    10.1 Amifostine Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Amifostine by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of Amifostine by Type (2022-2027)
    10.2 Amifostine Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Amifostine by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of Amifostine by Application (2022-2027)
    10.3 Amifostine Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Amifostine by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of Amifostine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer
List of Tables
    Table 1. Global Amifostine Sales (K Units) Growth Rate Comparison by Type (2021-2027)
    Table 2. Global Amifostine Sales (K Units) Comparison by Application (2021-2027)
    Table 3. Global Amifostine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
    Table 4. Key Manufacturers Amifostine Covered in This Study
    Table 5. Global Amifostine Sales (K Units) of Key Manufacturers (2016-2021)
    Table 6. Global Amifostine Sales Market Share by Manufacturers (2016-2021)
    Table 7. Global Amifostine Revenue (US$ Million) by Manufacturers (2016-2021)
    Table 8. Global Amifostine Revenue Share by Manufacturers (2016-2021)
    Table 9. Global Market Amifostine Average Price (USD/Unit) of Key Manufacturers (2016-2021)
    Table 10. Manufacturers Amifostine Manufacturing Sites and Area Served
    Table 11. Manufacturers Amifostine Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Amifostine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amifostine as of 2020)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Amifostine Sales by Region (2016-2021) & (K Units)
    Table 16. Global Amifostine Sales Market Share by Region (2016-2021)
    Table 17. Global Amifostine Revenue by Region (2016-2021) & (US$ Million)
    Table 18. North America Amifostine Sales by Country (2016-2021) & (K Units)
    Table 19. North America Amifostine Sales Market Share by Country (2016-2021)
    Table 20. North America Amifostine Revenue by Country (2016-2021) & (US$ Million)
    Table 21. North America Amifostine Revenue Market Share by Country (2016-2021)
    Table 22. Europe Amifostine Sales by Country (2016-2021) & (K Units)
    Table 23. Europe Amifostine Sales Market Share by Country (2016-2021)
    Table 24. Europe Amifostine Revenue by Country (2016-2021) & (US$ Million)
    Table 25. Europe Amifostine Revenue Market Share by Country (2016-2021)
    Table 26. Asia Pacific Amifostine Sales by Region (2016-2021) & (K Units)
    Table 27. Asia Pacific Amifostine Sales Market Share by Region (2016-2021)
    Table 28. Asia Pacific Amifostine Revenue by Region (2016-2021) & (US$ Million)
    Table 29. Asia Pacific Amifostine Revenue Market Share by Region (2016-2021)
    Table 30. Latin America Amifostine Sales by Country (2016-2021) & (K Units)
    Table 31. Latin America Amifostine Sales Market Share by Country (2016-2021)
    Table 32. Latin America Amifostine Revenue by Country (2016-2021) & (US$ Million)
    Table 33. Latin America Amifostine Revenue Market Share by Country (2016-2021)
    Table 34. Middle East and Africa Amifostine Sales by Country (2016-2021) & (K Units)
    Table 35. Middle East and Africa Amifostine Sales Market Share by Country (2016-2021)
    Table 36. Middle East and Africa Amifostine Revenue by Country (2016-2021) & (US$ Million)
    Table 37. Middle East and Africa Amifostine Revenue Market Share by Country (2016-2021)
    Table 38. Global Amifostine Sales (K Units) by Type (2016-2021)
    Table 39. Global Amifostine Sales Market Share by Type (2016-2021)
    Table 40. Global Amifostine Revenue (Million US$) by Type (2016-2021)
    Table 41. Global Amifostine Revenue Share by Type (2016-2021)
    Table 42. Global Amifostine Price (USD/Unit) by Type (2016-2021)
    Table 43. Global Amifostine Sales (K Units) by Application (2016-2021)
    Table 44. Global Amifostine Sales Market Share by Application (2016-2021)
    Table 45. Global Amifostine Revenue (Million US$) by Application (2016-2021)
    Table 46. Global Amifostine Revenue Share by Application (2016-2021)
    Table 47. Global Amifostine Price (USD/Unit) by Application (2016-2021)
    Table 48. Clinigen Corporation Information
    Table 49. Clinigen Description and Business Overview
    Table 50. Clinigen Amifostine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 51. Clinigen Amifostine Product
    Table 52. Clinigen Recent Developments/Updates
    Table 53. Sun Pharmaceutical Corporation Information
    Table 54. Sun Pharmaceutical Description and Business Overview
    Table 55. Sun Pharmaceutical Amifostine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 56. Sun Pharmaceutical Amifostine Product
    Table 57. Sun Pharmaceutical Recent Developments/Updates
    Table 58. Taj Pharmaceuticals Corporation Information
    Table 59. Taj Pharmaceuticals Description and Business Overview
    Table 60. Taj Pharmaceuticals Amifostine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 61. Taj Pharmaceuticals Amifostine Product
    Table 62. Taj Pharmaceuticals Recent Developments/Updates
    Table 63. Merro Pharmaceutical Corporation Information
    Table 64. Merro Pharmaceutical Description and Business Overview
    Table 65. Merro Pharmaceutical Amifostine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 66. Merro Pharmaceutical Amifostine Product
    Table 67. Merro Pharmaceutical Recent Developments/Updates
    Table 68. Luye Pharma Corporation Information
    Table 69. Luye Pharma Description and Business Overview
    Table 70. Luye Pharma Amifostine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 71. Luye Pharma Amifostine Product
    Table 72. Luye Pharma Recent Developments/Updates
    Table 73. Mingren Pharma Corporation Information
    Table 74. Mingren Pharma Description and Business Overview
    Table 75. Mingren Pharma Amifostine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 76. Mingren Pharma Amifostine Product
    Table 77. Mingren Pharma Recent Developments/Updates
    Table 78. Production Base and Market Concentration Rate of Raw Material
    Table 79. Key Suppliers of Raw Materials
    Table 80. Amifostine Distributors List
    Table 81. Amifostine Customers List
    Table 82. Amifostine Market Trends
    Table 83. Amifostine Growth Drivers
    Table 84. Amifostine Market Challenges
    Table 85. Amifostine Market Restraints
    Table 86. Global Amifostine Sales Forecast by Type (2022-2027) & (K Units)
    Table 87. Global Amifostine Sales Market Share Forecast by Type (2022-2027)
    Table 88. Global Amifostine Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 89. Global Amifostine Revenue Market Share Forecast by Type (2022-2027)
    Table 90. Global Amifostine Sales Forecast by Application (2022-2027) & (K Units)
    Table 91. Global Amifostine Sales Market Share Forecast by Application (2022-2027)
    Table 92. Global Amifostine Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 93. Global Amifostine Revenue Market Share Forecast by Application (2022-2027)
    Table 94. Global Amifostine Sales Forecast by Region (2022-2027) & (K Units)
    Table 95. Global Amifostine Sales Market Share Forecast by Region (2022-2027)
    Table 96. Global Amifostine Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 97. Global Amifostine Revenue Market Share Forecast by Region (2022-2027)
    Table 98. Research Programs/Design for This Report
    Table 99. Key Data Information from Secondary Sources
    Table 100. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Amifostine
    Figure 2. Global Amifostine Market Share by Type in 2020 & 2027
    Figure 3. 400mg/Dose Product Picture
    Figure 4. 500mg/Dose Product Picture
    Figure 5. Global Amifostine Market Share by Application in 2020 & 2027
    Figure 6. Head and Neck Cancer Adjuvant Therapy
    Figure 7. Others
    Figure 8. Global Amifostine Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 9. Global Amifostine Market Size 2016-2027 (US$ Million)
    Figure 10. Global Amifostine Sales 2016-2027 (K Units)
    Figure 11. Global Amifostine Market Size Market Share by Region: 2016 VS 20210 VS 2027
    Figure 12. Amifostine Sales Share by Manufacturers in 2020
    Figure 13. Global Amifostine Revenue Share by Manufacturers in 2020
    Figure 14. The Global 5 and 10 Largest Amifostine Players: Market Share by Revenue in 2020
    Figure 15. Amifostine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
    Figure 16. Global Amifostine Sales Market Share by Region (2016-2021)
    Figure 17. Global Amifostine Sales Market Share by Region in 2020
    Figure 18. Global Amifostine Revenue Market Share by Region (2016-2021)
    Figure 19. Global Amifostine Revenue Market Share by Region in 2020
    Figure 20. U.S. Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 21. Canada Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 22. Germany Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 23. France Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 24. U.K. Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 25. Italy Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 26. Russia Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 27. China Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 28. Japan Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 29. South Korea Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 30. India Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 31. Australia Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 32. Taiwan Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 33. Indonesia Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 34. Thailand Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 35. Malaysia Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 36. Philippines Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 37. Vietnam Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 38. Mexico Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 39. Brazil Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 40. Argentina Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 41. Turkey Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 42. Saudi Arabia Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 43. U.A.E Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 44. Sales Market Share of Amifostine by Type (2016-2021)
    Figure 45. Sales Market Share of Amifostine by Application (2016-2021)
    Figure 46. Sales Market Share of Amifostine by Application in 2020
    Figure 47. Revenue Share of Amifostine by Application (2016-2021)
    Figure 48. Revenue Share of Amifostine by Application in 2020
    Figure 49. Manufacturing Cost Structure of Amifostine
    Figure 50. Manufacturing Process Analysis of Amifostine
    Figure 51. Amifostine Industrial Chain Analysis
    Figure 52. Channels of Distribution
    Figure 53. Distributors Profiles
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Clinigen
Sun Pharmaceutical
Taj Pharmaceuticals
Merro Pharmaceutical
Luye Pharma
Mingren Pharma
Frequently Asked Questions
Amifostine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Amifostine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Amifostine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Box Making Machines

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More